You can read Part 1 here and Part 3 here.
ClearNote Health secures $52 million to scale early cancer detection and expand global clinical and commercial operations.
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
The study, titled ‘Multiple instance learning approach for automated gallbladder cancer detection using ultrasound imaging: ...
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test ...
Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced ...
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Goldman Sachs 47th Annual ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results